Bill Boyle

Cooley advised Ethos, an insurtech company that’s transforming the life insurance space, on its $100 million investment from SoftBank Vision Fund 2, which brings its valuation to $2.7 billion. Partner Seth Gottlieb led the Cooley team advising Ethos.

Cooley advised Lyell Immunopharma, a T cell reprogramming company dedicated to the mastery of T cells to cure patients with solid tumors, on its $425 million initial public offering of 25,000,000 shares of its common stock. Partners Dave Peinsipp, Charlie Kim, Chad Mills and Lauren Creel led the Cooley team advising Lyell on its public debut, which marks the third largest biotech IPO in history.

Cooley advised Ethos, an insurtech company that’s transforming the life insurance space, on its $200 million Series D financing round, which brings its valuation to more than $2 billion. Lawyers Seth Gottlieb, Matthew Bartus and Emily Iannarelli led the team advising Ethos.

Cooley advised Meesho, India’s leading social commerce platform, on raising $300 million in funding, which brings the company’s valuation to $2.1 billion. SoftBank Vision Fund 2 led the round, which also included participation from existing investors Prosus Ventures, Facebook, Shunwei Capital, Venture Highway and Knollwood Investment. Partners Ferish Patel and Patrick Loofbourrow led the Cooley team advising Meesho.

Cooley advised Clearlake Capital on its recent acquisitions of leading software solutions companies Perforce Software and ProVation Medical. Cooley partner Mehdi Khodadad led the teams advising Clearlake on the transactions.